Clinical Trials Logo
  1. Home
  2. NAFLD
  3. NCT06009250
  4. Details
NCT06009250 Clinical Trial

Prevalence of Non-alcoholic Fatty Liver Disease in Patients With Chronic Kidney Disease in Assiut

NAFLD Clinical Trial

Official title:
Prevalence of Non-alcoholic Fatty Liver Disease in Patients With Chronic Kidney Disease in Assiut

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT06009250
Other study ID # NAFLD and CKD
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date December 2023
Est. completion date December 2024

Study information
Verified date August 2023
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this observational study is to detect the prevalence of NAFLD in CKD patients The main question[s] it aims to answer are: - [question 1] prevalence of NAFLD in CKD patients. - [question 2] the relationship between NAFLD and CKD.

Description:

The goal of this observational study is to detect the prevalence of NAFLD in CKD patients The main question[s] it aims to answer are: - [question 1] prevalence of NAFLD in CKD patients. - [question 2] the relationship between NAFLD and CKD.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 200
Est. completion date December 2024
Est. primary completion date December 2024
Accepts healthy volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - CKD patients Exclusion Criteria: - HCV and HBV Positive patients - Alcoholics - patient on Hemodialysis - patients with wilson disease - patients with alpha one antitrypsin deficiency

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Muhammad Ameen Abdelrady Abdelaziz

Outcome
Type Measure Description Time frame Safety issue
Primary abdominal ultrasound assessment of Liver regarding fatty liver disease by Ultrasound. 1 year
Primary liver enzymes participants will undergo assessment of liver enzymes (AST and ALT) and results will be reporeted in a table. 1 year
Primary Fibroscan participants will undergo fibroscanning of the liver to assess NAFLD and results will be reported in a table. 1 year
Primary BUN, Cr level and estimated GFR participants will be assessed regarding BUN, CR and estimated GFR to confirm and follow up CKD patients involved in the study. 1 year
Primary Lipid Profile participants will be assessed regarding Cholesterol level, Triglycerides, HDL and LDL. results will be reported in a table 1 year
Primary Complete Blood Picture (WBCs, HB, Patelets total leucocytic count Hemoglobin level and platelet count will be assessed in our patients and will be reported in a table 1 year
Primary serum Uric Acid serum uric acid will be assessed and reported in our patients 1 year
Secondary Waist Circumference waist circumference measurement. 1 year
Secondary Body Mass Index BMI will also be calculated. 1 year
See also
  Status Clinical Trial Phase
Completed NCT06101433 - The Effect of Soy Isoflavones on Non-alcoholic Fatty Liver Disease and the Level of FGF-21 and Fetuin A N/A
Completed NCT03289897 - Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan N/A
Recruiting NCT05479721 - LITMUS Imaging Study
Completed NCT05527938 - Web-based Interventions on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Children N/A
Recruiting NCT06308757 - Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis N/A
Completed NCT02654977 - CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy Phase 2
Completed NCT02927184 - Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease Phase 2
Recruiting NCT06047847 - Determination of Biological Activity of Enriched Serum Following TOTUM-448 Consumption N/A
Active, not recruiting NCT03534908 - Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: the Correlation Analysis and Risk Prediction Model Study
Recruiting NCT06098417 - Biomarkers in the Diagnosis and Prognosis of NAFLD
Recruiting NCT04564391 - Whey or Casein - Liver Fat Reduction and Metabolic Improvement by Fast vs. Slow Proteins N/A
Not yet recruiting NCT05984745 - Effect of CoQ10 on the Outcome of MAFLD Patients Phase 2
Not yet recruiting NCT05052515 - The Effects of Natural Extracts Supplementation on NASH Patients N/A
Recruiting NCT02459496 - Diabetes Nutrition Algorithms in Patients With Overt Diabetes Mellitus N/A
Completed NCT01936779 - Understanding the Role of Dietary Fatty Acids on Liver Fat Metabolism in Humans N/A
Completed NCT05844137 - Improving Detection and Evidence-based Care of NAFLD in Latinx and Black Patients With Type 2 Diabetes N/A
Recruiting NCT04664036 - Prevalence, Incidence and Characteristics of NAFLD/NASH in Type 1 Diabetes Mellitus
Recruiting NCT04976283 - Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver Phase 4
Recruiting NCT03587298 - Use of Shear Wave Elastography to Assess Non-alcoholic Fatty Liver Disease (NAFLD)
Completed NCT02952170 - Impact of Weight Loss Surgery in Adolescents With NAFLD N/A